Connect with us

    Hi, what are you looking for?

    News

    NGF Holds Emergency Meeting on Distribution of COVID-19 Vaccine

    The Nigerian Governor’s Forum (NGF) will today hold an emergency online meeting to discuss how the 3.92 million doses of Oxford/AstraZeneca vaccines should be distributed in the country.

    The meeting is a single-item agenda where only the delivery of the Covid 19 vaccines and their distribution in the country would be discussed.

    The meeting would commence by 5 pm according to the invitation sent to the Governors by the Director-General of the Forum Mr. Asishana B Okauru.

    Governors are to begin to join at 4 pm.

    Nigeria, on Tuesday, received 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India(SII) and shipped via the COVAX Facility.

    The Presidential Task Force (PTF) on COVID-19, has also said that additional 84 million doses of the Oxford/AstraZeneca vaccine from COVAX are expected to be delivered this year, which will serve 20 percent of Nigeria’s over 200 million population.

     

    pmnews

    Spread the love
    Click to comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    ad

    You May Also Like

    Metro

    Economic and Financial Crimes Commission has recovered over N5bn and $10m from contractors and government officials indicted in the fraud in the turnaround maintenance...

    Tech

    Nigerian Communications Commission (NCC) has introduced a series of new regulations aimed at strengthening consumer protection and improving service delivery in the telecommunications sector....

    News

    Federal Government has reacted to the viral video showing a cleric flogging a group of m!nors in Port Harcourt, Rivers State. In a press...

    Tech

    Nigerian Communications Commission (NCC) is leading the charge to implement the Presidential Order that designates telecommunications infrastructure as Critical National Information Infrastructure (CNII). Under...